The next confirmation statement is due 24 Apr 2027 based on current public-register data.
Public company register page
ENVISION PHARMA BIDCO LIMITED
Companies House number 10118043. This page summarizes the public-register confirmation statement deadline and due date for this company, alongside officers, PSCs, and recent filing history from Companies House.
2 active officers currently exposed on the public register.
1 active people with significant control currently exposed on the public register.
Confirmation statement made on 2026-04-10 with updates on 10 Apr 2026
Entity Watch briefing
ENVISION PHARMA BIDCO LIMITED is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 24 Apr 2027, which is the next obvious register deadline to watch. The freshest filing signal is confirmation statement made on 2026-04-10 with updates on 10 Apr 2026.
The next confirmation statement is due 24 Apr 2027, 376 days from today, so this is the next obvious compliance checkpoint for the company record.
Only one active PSC is currently exposed on the public register, which points to a concentrated control profile rather than a broad shareholder picture.
The most recent filing is a confirmation statement update: Confirmation statement made on 2026-04-10 with updates on 10 Apr 2026. That usually means the company has refreshed its core register details rather than filed an operational or distress event.
This company has been on the public register since 11 Apr 2016 - roughly 10 years - which helps separate an established record from a newly formed one.
Quick answers about ENVISION PHARMA BIDCO LIMITED
These answer the exact register questions people usually search first.
When is the next confirmation statement due for ENVISION PHARMA BIDCO LIMITED?
The next confirmation statement due date currently shown on the public record is 24 Apr 2027.
Is ENVISION PHARMA BIDCO LIMITED overdue?
Entity Watch currently reads this company as no immediate confirmation-statement pressure. The next confirmation statement is due 24 Apr 2027 based on current public-register data.
Who are the active officers of ENVISION PHARMA BIDCO LIMITED?
The public register currently shows 2 active officers: DEUTSCH, Adam Brent, Mr., RUDNICK, Stanford Benjamin.
Who are the PSCs of ENVISION PHARMA BIDCO LIMITED?
The public register currently shows 1 active PSC: Envision Pharma Midco Limited.
What was the latest filing for ENVISION PHARMA BIDCO LIMITED?
The latest filing currently shown is Confirmation statement made on 2026-04-10 with updates dated 10 Apr 2026 with filing code CS01.
What CS01 meansWhat changed recently at ENVISION PHARMA BIDCO LIMITED?
ENVISION PHARMA BIDCO LIMITED is currently listed as active and recorded as a ltd on the public register. The next confirmation statement is due 24 Apr 2027, which is the next obvious register deadline to watch. The freshest filing signal is confirmation statement made on 2026-04-10 with updates on 10 Apr 2026.
Company facts
Envision House, 5 North Street, Horsham, West Sussex, RH12 1XQ
11 Apr 2016
24 Apr 2027
10 Apr 2027
Officers
Current public-register officers for this company.
Director
Appointed 20 Aug 2024
Director
Appointed 9 Dec 2024
Recent filing history
Latest filing events exposed through the Companies House filing-history API.
Confirmation statement made on 2026-04-10 with updates10 Apr 2026
Form CS01. Filed on 2026-04-10.
Statement of capital following an allotment of shares on 2026-02-0925 Feb 2026
Form SH01. Filed on 2026-02-25. Capital recorded: USD 0.19.
Audit exemption subsidiary accounts made up to 2024-12-3110 Jan 2026
Form AA. Filed on 2026-01-10.
Consolidated accounts of parent company for subsidiary company period ending 31/12/2410 Jan 2026
Form PARENT_ACC. Filed on 2026-01-10.
Audit exemption statement of guarantee by parent company for period ending 31/12/2410 Jan 2026
Form GUARANTEE2. Filed on 2026-01-10.
Notice of agreement to exemption from audit of accounts for period ending 31/12/2410 Jan 2026
Form AGREEMENT2. Filed on 2026-01-10.
Confirmation statement made on 2025-04-10 with no updates10 Apr 2025
Form CS01. Filed on 2025-04-10.
Director's details changed for Stanford Benjamin Rudnick on 2024-12-0928 Feb 2025
Form CH01. Filed on 2025-02-28.
Appointment of Stanford Benjamin Rudnick as a director on 2024-12-0910 Feb 2025
Form AP01. Filed on 2025-02-10.
Termination of appointment of Howard Collins Miller Iii as a director on 2024-12-3124 Jan 2025
Form TM01. Filed on 2025-01-24.
Termination of appointment of Joshua Hollis Korth as a director on 2024-11-1524 Jan 2025
Form TM01. Filed on 2025-01-24.
Appointment of Mr. Adam Brent Deutsch as a director on 2024-08-2029 Oct 2024
Form AP01. Filed on 2024-10-29.